Top

Published in:

01-09-2017 | Case report

Canakinumab

Injection site reaction: case report

Published in: Reactions Weekly | Issue 1/2017

Excerpt

In an observational retrospective study, one patient [age and sex not stated] was described, who developed injection site reaction during treatment with canakinumab. The patient had Muckle–Wells syndrome for which the patient was treated with canakinumab. The patient received SC canakinumab 150mg [frequency not stated]. Following the administration, the patient developed injection site reaction [time to reaction onset and outcome not stated]. …

Guerrero LJ, et al. Study of the use of canakinumab in muckle-wells syndrome in a tertiary hospital. European Journal of Hospital Pharmacy - Science and Practice 24 (Suppl. 1): A149, Mar 2017 [abstract] - Spain

Title: Canakinumab
Injection site reaction: case report
Publication date: 01-09-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-35565-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Canakinumab

Injection site reaction: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Esomeprazole/omeprazole

Cimetidine/loperamide

Methotrexate/prednisone

Bupivacaine

Dabrafenib/vemurafenib

Rituximab